Yabao Pharmaceutical (600351.SH): Obtained the registration certificate for Kelifol ointment.

Zhitong Finance and Economics APP News, Yabao Pharmaceutical (600351.SH) announced that recently, the company received the "Drug Registration Certificate" for Kliboro ointment issued and approved by the National Medical Products Administration. Kliboro ointment is suitable for local external treatment of mild to moderate atopic dermatitis patients aged 3 months and above.